News

Emyria starts program with neuroscience drug discovery CRO

By Jim Cornall · Sept 22, 2022 · Labiotech.eu Emyria Limited, a clinical stage biotech, is set to work with PsychoGenics,...

News

Clinical Catch-Up: Updates in Solid Tumors, ALS, Migraine and More

By Vanessa Doctor, RN · Sep 22, 2022 · BioSpace It’s been a busy week across the clinical development space, with...

News

Emyria teams with CRO PsychoGenics for MDMA-like drug development

By Joseph Keenan · Sep 21, 2022 · Fierce Biotech Australian biotech Emyria and U.S.-based CRO PsychoGenics have agreed to a collaborate on...

News

Overcoming mental health’s drug development challenges with AI

By Kelly Bilodeau · Aug. 23, 2022 · PharmaVoice PsychoGenics is leveraging AI-driven drug discovery platforms to advance mental health treatments...

News

PsychoGenics – Phenotypic Drug Discovery and Preclinical CRO

Aug. 22, 2022 · Health Professional Radio Mark Varney, Ph.D., Chief Scientific Officer of PsychoGenics, an AI-enabled phenotypic drug discovery and preclinical...

News

Industrializing behavioral testing to redefine neuropsychiatric drug discovery

PsychoGenics uses a high-throughput platform comprising cameras and AI to analyze the behaviors of mice given a drug candidate before...

News

We need a new Prozac: The demand for brain drug innovation

[et_pb_section fb_built=”1″ _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title meta=”off” featured_image=”off” _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][/et_pb_post_title][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”]...

News

Mental Health Champions: Why & How Dr. Emer Leahy of PsychoGenics Is Helping To Champion Mental Wellness

By Yitzi Weiner · Aug. 14, 2022 · Medium Delegate and accept imperfection — I find myself getting anxious when...

News

The CNS drug development drum beat is getting louder

By Brian Buntz | August 1, 2022 [image courtesy of Pixabay] The late 1980s and the 1990s were something of a gold rush...

News

PsychoGenics Strengthens Executive Team to Boost CNS Drug Discovery and CRO Capabilities

Biopharmaceutical Industry Veterans David Bleakman and Thomas Oakley Each Bring Three Decades of Experience to the Company Paramus, N.J., June...

Partner with us and transform your program

DISCOVER YOUR NEXT BREAKTHROUGH WITH PSYCHOGENICS

Get Started